Research In Brief
This article was originally published in The Tan Sheet
Ibuprofen & Alzheimer's: Analgesic may protect against disease due to inhibition of amyloid-beta 42 peptide, a protein found in plaque that kills brain cells of Alzheimer's patients, researchers report in Nov. 8 Nature. Sascha Weggen, UC-San Diego, et al., found 250 mM ibuprofen dissolved in ethanol decreased Aß42 peptide in cultured cells by up to 80%. Also, ibuprofen treatment in three-month old mice "resulted in a highly significant 39% decrease in levels of Aß42...compared with mock-treated animals," researchers report. However, aspirin, naproxen, other NSAIDs showed negative results, indicating a lack of ability to lower Aß42 levels. Although researchers previously believed NSAIDs' mechanism of action was their anti-inflammatory properties, Weggen et al. note "this Aß42 activity may be an important criterion to consider in...trials of NSAIDs for the treatment of Alzheimer's disease"...
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC